These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27632954)

  • 1. Epstein-Barr virus latent membrane protein-1 up-regulates cytokines and correlates with older age and poorer prognosis in Hodgkin lymphoma.
    Chang KC; Chen PC; Chang Y; Wu YH; Chen YP; Lai CH; Medeiros LJ; Su IJ; Wang HW
    Histopathology; 2017 Feb; 70(3):442-455. PubMed ID: 27632954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus latent membrane protein-1 upregulates autophagy and promotes viability in Hodgkin lymphoma: Implications for targeted therapy.
    Lin HC; Chang Y; Chen RY; Hung LY; Chen PC; Chen YP; Medeiros LJ; Chiang PM; Chang KC
    Cancer Sci; 2021 Apr; 112(4):1589-1602. PubMed ID: 33525055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients.
    Spacek M; Hubacek P; Markova J; Zajac M; Vernerova Z; Kamaradova K; Stuchly J; Kozak T
    APMIS; 2011 Jan; 119(1):10-6. PubMed ID: 21143522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
    Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
    Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of Epstein-Barr virus (EBV) infection in Hodgkin lymphoma patients.
    Myriam BD; Sonia Z; Hanene S; Teheni L; Mounir T
    J Infect Chemother; 2017 Mar; 23(3):121-130. PubMed ID: 28034523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationships between Epstein-Barr virus latent membrane protein 1 and regulatory T cells in Hodgkin's lymphoma.
    Marshall NA; Culligan DJ; Tighe J; Johnston PW; Barker RN; Vickers MA
    Exp Hematol; 2007 Apr; 35(4):596-604. PubMed ID: 17379070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Epstein Barr viral load in adult-onset Hodgkin lymphoma in South India.
    Sinha M; Rao CR; Shafiulla M; Shankaranand B; Viveka BK; Lakshmaiah KC; Jacob LA; Babu GK; Jayshree RS
    Hematol Oncol Stem Cell Ther; 2016 Mar; 9(1):8-13. PubMed ID: 26657995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-associated Hodgkin's lymphoma.
    Gandhi MK; Tellam JT; Khanna R
    Br J Haematol; 2004 May; 125(3):267-81. PubMed ID: 15086409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus infection induces an increase of T regulatory type 1 cells in Hodgkin lymphoma patients.
    Morales O; Mrizak D; François V; Mustapha R; Miroux C; Depil S; Decouvelaere AV; Lionne-Huyghe P; Auriault C; de Launoit Y; Pancré V; Delhem N
    Br J Haematol; 2014 Sep; 166(6):875-90. PubMed ID: 25041527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study.
    Keegan TH; Glaser SL; Clarke CA; Gulley ML; Craig FE; Digiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
    J Clin Oncol; 2005 Oct; 23(30):7604-13. PubMed ID: 16186595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus encoded latent membrane protein 1 (LMP1) and TNF receptor associated factors (TRAF): colocalisation of LMP1 and TRAF1 in primary EBV infection and in EBV associated Hodgkin lymphoma.
    Siegler G; Kremmer E; Gonnella R; Niedobitek G
    Mol Pathol; 2003 Jun; 56(3):156-61. PubMed ID: 12782762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma.
    Kwon JM; Park YH; Kang JH; Kim K; Ko YH; Ryoo BY; Lee SS; Lee SI; Koo HH; Kim WS
    Ann Hematol; 2006 Jul; 85(7):463-8. PubMed ID: 16534596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
    Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
    J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells.
    Baumforth KR; Birgersdotter A; Reynolds GM; Wei W; Kapatai G; Flavell JR; Kalk E; Piper K; Lee S; Machado L; Hadley K; Sundblad A; Sjoberg J; Bjorkholm M; Porwit AA; Yap LF; Teo S; Grundy RG; Young LS; Ernberg I; Woodman CB; Murray PG
    Am J Pathol; 2008 Jul; 173(1):195-204. PubMed ID: 18502823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latent membrane protein 1 (LMP1) expression in Hodgkin lymphoma and its correlation with clinical and histologic parameters.
    Hashmi AA; Hussain ZF; Hashmi KA; Zafar MI; Edhi MM; Faridi N; Khan M
    World J Surg Oncol; 2017 Apr; 15(1):89. PubMed ID: 28427406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the Epstein-Barr virus positivity on Hodgkin's lymphoma in a large cohort from a single institute in Korea.
    Koh YW; Yoon DH; Suh C; Huh J
    Ann Hematol; 2012 Sep; 91(9):1403-12. PubMed ID: 22526365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of Epstein-Barr virus infection and childhood lymphoma].
    Xie ZD; Wang L; Lu D; Zhou CJ; Shen KL
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):365-7. PubMed ID: 18953837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin's lymphoma.
    Claviez A; Tiemann M; Lüders H; Krams M; Parwaresch R; Schellong G; Dörffel W
    J Clin Oncol; 2005 Jun; 23(18):4048-56. PubMed ID: 15961758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical characteristics and prognosis analysis of patients with LMP-1 positive Hodgkin's lymphoma after EBV infection].
    Ping LY; Ding N; Shi YF; Sun L; Zheng W; Xie Y; Wang XP; Tu MF; Lin NJ; Ying ZT; Liu WP; Deng LJ; Zhan C; Tian L; Feng LX; Song YQ; Zhu J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):78-84. PubMed ID: 24598656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hodgkin's disease and Epstein-Barr virus].
    Depil S; Moralès O; Auriault C
    Ann Biol Clin (Paris); 2004; 62(6):639-48. PubMed ID: 15563422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.